Phase 3 IFx-Hu2.0 trial as an adjunctive therapy with Keytruda® (pembrolizumab) in checkpoint inhibitor (CPI)-naïve patients with advanced or metastatic Merkel cell carcinoma (MCC) detailed in...

Eli Lilly and Company (NYSE: LLY) today announced new Phase 1 data showing that its folate receptor alpha (FRα) antibody-drug conjugate (ADC) (LY4170156) demonstrated an encouraging safety...

Arthrosi Therapeutics, Inc., a late-stage biotechnology company developing a potentially best-in-class, highly potent and selective next generation URAT1 inhibitor to reduce serum urate (sUA)...

Fiber Connect 2025, Booth 429 – Lightera, a global leader in innovative fiber optic solutions, proudly announces the launch of the InvisiLight™ Home Fiber Kit, a revolutionary...

Favorable safety profile and encouraging early efficacy signals support advancement to Phase II trial of dendritic cell vaccine for the treatment of glioblastoma. HOUSTON, June 2, 2025 /PRNewswire/ --

RollR® 200 864 Fiber Rollable Ribbon Microcable delivers outstanding fiber density and installation efficiency NASHVILLE, Tenn., June 2, 2025 /PRNewswire/ -- Fiber Connect 2025, Booth 429 –...

RaySearch Laboratories AB (publ) will exhibit at PTCOG 63, held June 3-6, 2025, in Buenos Aires, Argentina. At booth #08, the company will showcase its latest software innovations driving the...

AZZ Inc. (NYSE: AZZ), the leading independent provider of hot-dip galvanizing and coil coating solutions in North America, today announced that David Nark, Chief Marketing, Communications, and...

IDEAYA Biosciences, Inc. (NASDAQ: IDYA), a precision medicine oncology company committed to the discovery and development of targeted therapeutics, announced its participation in the upcoming...

STARTUP AUTOBAHN's flagship Expo event returns on June 5, 2025, for its 14th edition, showcasing collaborative projects and breakthrough innovations from startups and industry leaders across...